Sales of Rare Neurodegenerative Disease Treatment Market to Reach US$ 116 Bn by 2030 The global rare neurodegenerative disease treatment market is projected to witness steady growth at a CAGR of 5%, reaching a valuation of over US$ 116 billion by 2030. However, the coronavirus outbreak is expected to have a marginally negative impact on the industry in the short term. Supply chain issues and dedication of healthcare facilities towards handling the unprecedented challenges of the pandemic are hindering market growth at present. For detailed insights on enhancing your product footprint, request for a sample here - https://www.factmr.com/connectus/sample?flag=S&rep_id=5197 On the other hand, increasing investments by market players towards drug development for the treatment of neurodegenerative diseases, and rising awareness among patients about varied treatment options, are major contributors to the growth of the market. Also, rise in medical tourism and investments towards modernization of healthcare infrastructure across developing countries in Asia Pacific are expected to benefit the rare neurodegenerative disease treatment market in the long term. Key Takeaways from Rare Neurodegenerative Disease Treatment Market Study
North America is a prominent regional market, accounting for a major market share on the back of high healthcare expenditure and the presence of top pharmaceutical manufacturers in the region. Hospital pharmacies are the leading channel of distribution for drugs associated with neurodegenerative diseases, driven by larger inventories. Multiple sclerosis is the leading indication in the rare neurodegenerative disease treatment market, supported by growing awareness about the disease and rise in cases in recent years. Sales of neuroprotective agents are essential for market revenue, with popularity supported by reduced side effects. The COVID-19 pandemic is expected to have a moderate adverse impact on the global rare neurodegenerative disease treatment market in the short term.
For critical insights on this market, request for methodology here - https://www.factmr.com/connectus/sample?flag=RM&rep_id=5197 Key Segments of Rare Neurodegenerative Disease Treatment Market Fact.MR’s study on the rare neurodegenerative disease treatment market offers information divided into four important segments - indication, drug class, distribution channel, and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories. Drug Class
Neurotransmitter Agents Neuroprotective Agents Biologics Others
Distribution Channel
Hospital Pharmacies